Vaccination

(asked on 22nd October 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the covid-19 outbreak on vaccination rates for adult vaccinations.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 5th November 2020

The pneumococcal polysaccharide vaccine (PPV) is offered to adults aged 65 and over and children and adults in a clinical risk group. PPV coverage for the 2019-20 financial year was 69.0% (10,115,593/ 6,975,469) in adults aged 65 years and older. These results do not show the impact of the COVID-19 as most individuals were offered the vaccine prior to when lockdown measures were enforced. PPV vaccine coverage estimates for the 2020-21 financial year will reflect adults turning 65 and over from April 2020 to March 2021, which covers the duration when lockdown measures were enforced. This data will be published in summer of 2021.

The shingles vaccine is offered to those turning 70 or 78 years old up to their 80th birthday. Disruption to the delivery of the vaccine caused by COVID-19 and shielding guidance accounts for lower coverage. Annual vaccine coverage was 5.4 and 7.1 percentage points lower for 70- and 78-year olds compared to last year, with coverage in 2019/20 quarter 4 being 3.8 and 3.4 percentage points lower than 2018/19 quarter 4, respectively.

Reticulating Splines